We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04326426
Recruitment Status : Unknown
Verified April 2020 by Vanda Pharmaceuticals.
Recruitment status was:  Enrolling by invitation
First Posted : March 30, 2020
Last Update Posted : April 20, 2020
Information provided by (Responsible Party):
Vanda Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : August 1, 2020
Estimated Study Completion Date : August 31, 2020